Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of bax and translocation of mitochondrial cytochrome C independent of COX-2 expression

Neoplasia

Volumn 2, Issue 4, 2000, Pages 346-356

  Aggarwal, Sanjeev ^a   Taneja, Neelam ^a   Lin, Lin ^a   Orringer, Mark B ^a   Rehemtulla, Alnawaz ^a   Beer, David G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Barrett's esophagus; Chemoprevention; Esophageal adenocarcinoma; NSAIDs

Indexed keywords

CASPASE 9; CASPASE INHIBITOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME C OXIDASE; DNA FRAGMENT; INDOMETACIN; MITOCHONDRIAL ENZYME; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BAX; RNA;

ADENOCARCINOMA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CANCER PREVENTION; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0033812743     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900097     Document Type: Article

References (39)

1. The changing epidemiology of esophageal cancer
2. Aspirin use and reduced risk of fatal colon cancer
3. NSAID use and decreased risk of gastrointestinal cancers
4. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment
5. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin
6. The role of cyclooxygenases in inflammation, cancer, and development
7. Identification of a phorbol ester-repressible v-src-inducible gene
8. Expression of cyclooxygenase- 1 and -2 in human colorectal cancer
9. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas
10. Overexpression of cyclooxygenase-2 in human prostate adenocarcinoma
11. Cyclooxygenase-2 expression in human esophageal carcinoma
12. Expression of cyclooxygenase-2 in human lung carcinoma
13. Cyclooxygenase-2 as a therapeutic target
14. Suppression of intestinal polyposis in Apc(Δ716) knockout mice by inhibition of cyclooxygenase-2 (COX-2)
15. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
16. Sulindac suppresses tumorigenesis in the Min mouse
17. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
18. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent
19. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
20. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT- 29 colon adenocarcinoma cells
21. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
22. 2) against indomethacin
23. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction
24. Evidence that prostaglandins do not have a role in the cytostatic action of anti-inflammatory drugs
25. Nonsteroidal anti-inflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts
26. Cyclooxygenase-2 inhibitors: A new class of anti-inflammatory agents that spare the gastrointestinal tract
27. Caspases: The proteases of the apoptotic pathway
28. Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas
29. Fas/APO-1 is not translocated to the cell membrane in esophageal adenocarcinoma
30. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1)
31. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-X(L)
32. Apoptosis in the pathogenesis and treatment of disease
33. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
34. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitorf against colon carcinogenesis
35. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX -2) -selective nonsteroidal anti- inflammatory drug: Independence from COX-2 protein expression
36. Cyclooxygenase- 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice
37. The Bcl-2 protein family: Arbiters of cell survival
38. Mitochondria and apoptosis
39. Apoptotic cytosol facilitates Bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2